医学
葡萄膜炎
抗菌剂
病因学
重症监护医学
抗感染药
免疫学
皮肤病科
病理
微生物学
生物
作者
Evangeline Leong,Carlos Cifuentes‐González,Jeremy Hu Y. W.,Ramar Perumal Samy,Moncef Khairallah,William Rojas‐Carabali,Ikhwanuliman Putera,Alejandra de‐la‐Torre,Rupesh Agrawal
标识
DOI:10.1080/09273948.2024.2345848
摘要
Infectious uveitis is a major global cause of vision impairment. Despite the eye's immune privilege, afforded by the blood-ocular barrier that restricts microbial entry, several pathogens such as bacteria, viruses, fungi, and parasites can still infiltrate and cause ocular infections and complications. Clinicians often encounter significant challenges in treating infectious uveitis due to limited or ineffective treatment options. Modern molecular techniques and imaging can aid in diagnosing and assessing intraocular infections. Various antimicrobial therapies exist, spanning topical and systemic treatments, but these are constrained by issues like drug concentration, penetration, effective duration, toxicity, and side effects. Treatment approaches also differ based on the infection's etiology. This review provides recent updates on antimicrobial therapies from a clinical perspective, covering topical, systemic, and regional treatments for infectious uveitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI